Home › Funds › Blue Water Life Science Advisors, LP › CDNA
Blue Water Life Science Advisors, LP position in CDNA
CAREDX INC · Health Care
Blue Water Life Science Advisors, LP reported holding 1,740,000 shares of CDNA (CAREDX INC) in its Q3 2026 13F filing — a position valued at US$113.1M, representing 44.96% of its reported portfolio and ranking #1 among its reported holdings. Blue Water Life Science Advisors, LP has disclosed CDNA holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Blue Water Life Science Advisors, LP's CDNA position evolved
Blue Water Life Science Advisors, LP first disclosed a stake in CDNA in Q2 2024 at 510,000 shares (US$7.9M). The position peaked in Q3 2026 at 1,740,000 shares, worth US$113.1M. Across 10 filings, Blue Water Life Science Advisors, LP increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 1,740,000 shares valued at US$113.1M — an increase of 550,000 shares quarter over quarter.. Notable position changes include a 30% trim in Q3 2025 (shares rose 30% over the following quarter), a 83% increase in Q1 2026 (shares rose 64% over the following quarter), a 46% increase in Q3 2026 (shares rose 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 510.00K | $7.92M | New |
| Q3 2024 | 604.00K | $18.86M | Add |
| Q4 2024 | 604.00K | $12.93M | Hold |
| Q1 2025 | 724.01K | $12.85M | Add |
| Q2 2025 | 724.01K | $14.15M | Hold |
| Q3 2025 | 510.00K | $7.42M | Reduce |
| Q4 2025 | 510.00K | $9.61M | Hold |
| Q1 2026 | 935.00K | $16.23M | Add |
| Q2 2026 | 1.19M | $33.91M | Add |
| Q3 2026 | 1.74M | $113.10M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CDNA and 13F data
CDNA (CAREDX INC) is a Health Care company. 47 other funds we track also report a position in CDNA — the largest reported positions include ARK Invest (US$104.6M), GAGNON SECURITIES LLC (US$69.8M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$56.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CDNA
- ARK Invest 1.61M sh · $104.59M · Q3 2026
- GAGNON SECURITIES LLC 1.07M sh · $69.84M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 2.00M sh · $56.93M · Q2 2026
- Amova Asset Management Americas, Inc. 625.42K sh · $40.63M · Q3 2026
- Ophir Asset Management Pty Ltd 1.26M sh · $36.05M · Q2 2026
- BRAIDWELL LP 1.22M sh · $34.79M · Q2 2026
- Zweig-DiMenna Associates LLC 389.81K sh · $25.34M · Q3 2026
- Divisadero Street Capital Management, LP 700.94K sh · $19.98M · Q2 2026
- Portolan Capital Management, LLC 684.80K sh · $19.52M · Q2 2026
- Gagnon Advisors, LLC 286.89K sh · $18.65M · Q3 2026
- Palo Alto Investors LP 531.87K sh · $15.16M · Q2 2026
More on Blue Water Life Science Advisors, LP
FAQ
How long has Blue Water Life Science Advisors, LP held CDNA?
Blue Water Life Science Advisors, LP has disclosed CDNA holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is Blue Water Life Science Advisors, LP's current position in CDNA?
As of Q3 2026, Blue Water Life Science Advisors, LP holds 1.74M shares of CDNA (CAREDX INC), valued at $113.10M, representing 44.96% of its reported portfolio and ranking #1.
Has Blue Water Life Science Advisors, LP been buying or selling CDNA?
In the latest 13F filing (Q3 2026), Blue Water Life Science Advisors, LP increased its position in CDNA. The position peaked in Q3 2026 at 1.74M shares.
Which other funds hold CDNA?
Other major institutional holders of CDNA include ARK Invest, GAGNON SECURITIES LLC, DEERFIELD MANAGEMENT COMPANY, L.P., among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.